We narrowed to 55,758 results for: ran
- 
  Plasmid#204859PurposeFor cytosine base editing using miniSdd7 in monocotyledon plants (transient transformation)DepositorInsertminiSdd7-nSpCas9(D10A)-UGI
 UseCRISPRExpressionPlantMutationD10A in SpCas9PromoterZmUbi-1Available SinceAug. 17, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pEGFP-N1 Full length Importin betaPlasmid#106941PurposeTransient expression of GFP-tagged Importin beta in mammalian cells (CMV promoter)DepositorInserthuman Importin beta-1 (KPNB1) (KPNB1 Human)
 TagsGFPExpressionMammalianPromoterCMV promoterAvailable SinceFeb. 22, 2018AvailabilityAcademic Institutions and Nonprofits only
- 
  p2T-CMV-miniSdd7-BE4max-BlastRPlasmid#204851PurposeFor cytosine base editing using miniSdd7 in mammalian cellsDepositorInsertminiSdd7-nSpCas9(D10A)-UGI
 UseCRISPRExpressionMammalianMutationD10A in SpCas9PromoterCMV, SV40, EM7Available SinceAug. 17, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  p2T-CMV-miniSdd6-BE4max-BlastRPlasmid#204850PurposeFor cytosine base editing using miniSdd6 in mammalian cellsDepositorInsertminiSdd6-nSpCas9(D10A)-UGI
 UseCRISPRExpressionMammalianMutationD10A in SpCas9PromoterCMV, SV40, EM7Available SinceAug. 17, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pZac2.1 EFs-SaCas9-U6-Sa DMDR7-U6-SaDMDL2Plasmid#78607PurposeA single vector AAV-Cas9 system containing SaCas9 under EFs promoter, gRNAs targeting Dmd introns 22 and 23DepositorInsertEFs-SaCas9-U6-Sa DMDR7-U6-SaDMDL2
 UseAAV and CRISPRTagsHA tagExpressionMammalianPromoterEF1a-short; U6Available SinceSept. 16, 2017AvailabilityAcademic Institutions and Nonprofits only
- 
  pZac2.1 CMV173-SaCas9-U6-SaDMDR7-U6-SaDMDL2Plasmid#78606PurposepZac2.1 CMV173-SaCas9-U6-SaDMDR7-U6-SaDMDL2DepositorInsertCMV173-SaCas9-U6-SaDMDR7-U6-SaDMDL2
 UseAAV and CRISPRTagsHA tagExpressionMammalianPromoter173CMV, U6Available SinceDec. 16, 2017AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV-Syn-SomaXCaMPRPlasmid#232845PurposeAAV transfer plasmid for Syn-mediated expression of soma-targeted XCaMPRDepositorInsertSomaXCaMPR
 UseAAVExpressionMammalianPromoterSynAvailable SinceAug. 4, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  pnCas9-miniSdd3-PBEPlasmid#204857PurposeFor cytosine base editing using miniSdd3 in monocotyledon plants (transient transformation)DepositorInsertminiSdd3-nSpCas9(D10A)-UGI
 UseCRISPRExpressionPlantMutationD10A in SpCas9PromoterZmUbi-1Available SinceAug. 17, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pCMV-TALE-R-JAK2-Ddd9-CPlasmid#204854PurposeFor DdCBE editing using Ddd9 at JAK2 site in human cellsDepositorInsertDdd9-C
 UseCRISPRExpressionMammalianPromoterCMVAvailable SinceAug. 17, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pCMV-TALE-L-JAK2-Ddd9-NPlasmid#204853PurposeFor DdCBE editing using Ddd9 at JAK2 site in human cellsDepositorInsertDdd9-N
 UseCRISPRExpressionMammalianPromoterCMVAvailable SinceAug. 17, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  p2T-CMV-miniSdd3-BE4max-BlastRPlasmid#204849PurposeFor cytosine base editing using miniSdd3 in mammalian cellsDepositorInsertminiSdd3-nSpCas9(D10A)-UGI
 UseCRISPRExpressionMammalianMutationD10A in SpCas9PromoterCMV, SV40, EM7Available SinceAug. 17, 2023AvailabilityAcademic Institutions and Nonprofits only
- 
  pMVP and pMAGIC Cloning SystemsPlasmid Kit#1000000155PurposepMVP and pMAGIC are cloning systems for adenoviral, lentiviral, expression, PiggyBac transposon, and Sleeping Beauty transposon vectors for transgene or RNAi delivery and dCas9-based engineering.DepositorAvailable SinceSept. 6, 2019AvailabilityAcademic Institutions and Nonprofits only
- 
  AiP11839-pAAV-hSyn1-SYFP2-10aa-H2B-WPRE3-BGHpA (Alias: CN1839) (AAV PHP.eB)Viral Prep#163509-PHPeBPurposeReady-to-use AAV PHP.eB particles produced from AiP11839-pAAV-hSyn1-SYFP2-10aa-H2B-WPRE3-BGHpA (Alias: CN1839) (#163509). In addition to the viral particles, you will also receive purified AiP11839-pAAV-hSyn1-SYFP2-10aa-H2B-WPRE3-BGHpA (Alias: CN1839) plasmid DNA. hSyn1-driven expression for nuclear SYFP2 labeling in neurons. Useful for nuclear isolation and scRNA-seq applications. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynTagsSYFP2Available SinceAug. 17, 2022AvailabilityAcademic Institutions and Nonprofits only
- 
  AiP11390-pAAV-DLX2.0-minBG-SYFP2-WPRE3-BGHpA (Alias: CN1390) (AAV PHP.eB)Viral Prep#163505-PHPeBPurposeReady-to-use AAV PHP.eB particles produced from AiP11390-pAAV-DLX2.0-minBG-SYFP2-WPRE3-BGHpA (Alias: CN1390) (#163505). In addition to the viral particles, you will also receive purified AiP11390-pAAV-DLX2.0-minBG-SYFP2-WPRE3-BGHpA (Alias: CN1390) plasmid DNA. AAV vector for strong and rapid SYFP2 expression in forebrain GABAergic interneurons. The enhancer core sequence has 100% sequence conservation between mouse and human. Developed especially for rapid viral labeling in human and NHP organotypic brain slice culture. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorPromoterminBetaGlobinTagsSYFP2Available SinceAug. 17, 2022AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV_BiPVe3_GCaMP6f (AAV PHP.eB)Viral Prep#213943-PHPeBPurposeReady-to-use AAV PHP.eB particles produced from pAAV_BiPVe3_GCaMP6f (#213943). In addition to the viral particles, you will also receive purified pAAV_BiPVe3_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the PV+ basket cell-targeting enhancer E3. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorAvailable SinceSept. 23, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV_BiSSTe4_GCaMP6f (AAV PHP.eB)Viral Prep#213947-PHPeBPurposeReady-to-use AAV PHP.eB particles produced from pAAV_BiSSTe4_GCaMP6f (#213947). In addition to the viral particles, you will also receive purified pAAV_BiSSTe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the SST interneuron-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorAvailable SinceSept. 23, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV_BiCHATe27_GCaMP6f (AAV PHP.eB)Viral Prep#213833-PHPeBPurposeReady-to-use AAV PHP.eB particles produced from pAAV_BiCHATe27_GCaMP6f (#213833). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the cholinergic neuron-targeting enhancer E27. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorAvailable SinceSept. 29, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV_BiPVe4_GCaMP6f (AAV PHP.eB)Viral Prep#213939-PHPeBPurposeReady-to-use AAV PHP.eB particles produced from pAAV_BiPVe4_GCaMP6f (#213939). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the chandelier cell-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorAvailable SinceSept. 23, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  pAAV_BiVIPe4_GCaMP6f (AAV PHP.eB)Viral Prep#213859-PHPeBPurposeReady-to-use AAV PHP.eB particles produced from pAAV_BiVIPe4_GCaMP6f (#213859). In addition to the viral particles, you will also receive purified pAAV_BiVIPe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the VIP interneuron-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorAvailable SinceSept. 23, 2025AvailabilityAcademic Institutions and Nonprofits only
- 
  AiP1636 - pAAV-AiE2116m-minBG-iCre-WPRE-BGHpA (AAV5)Viral Prep#230681-AAV5PurposeReady-to-use AAV5 particles produced from AiP1636 - pAAV-AiE2116m-minBG-iCre-WPRE-BGHpA (#230681). In addition to the viral particles, you will also receive purified AiP1636 - pAAV-AiE2116m-minBG-iCre-WPRE-BGHpA plasmid DNA. minBG-driven expression of iCre recombinase in specific populations of brain cells. These AAV preparations are suitable purity for injection into animals.DepositorPromoterminBGAvailable SinceAug. 6, 2025AvailabilityAcademic Institutions and Nonprofits only
 
       
       
       
       
       
       
       
      